Archive for January 3rd, 2009

M2 Presswire - FDA grants priority review to Diovan for heart failure indication.

Saturday, January 3rd, 2009

M2 PRESSWIRE-14 June 2001-NOVARTIS: FDA grants priority review to Diovan for heart failure indication (C)1994-2001 M2 COMMUNICATIONS LTD RDATE:13062001 Basel — Novartis today announced that the US Food and Drug Administ…